Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00979862
Recruitment Status : Completed
First Posted : September 18, 2009
Last Update Posted : April 15, 2015
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2012
  Actual Study Completion Date : February 2014